Download PDF
Clin Colon Rectal Surg 2002; 15(2): 097-104
DOI: 10.1055/s-2002-32057
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Polyp Growth and Polyp-Cancer Sequence

Marilyn J. Borst, David A. Margolin
  • Division of Colon and Rectal Surgery, Henry Ford Hospital, Detroit, MI
Further Information

Publication History

Publication Date:
06 June 2002 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Neoplastic polyps (tubular adenomas, villous adenomas, and tubulovillous adenomas) may progress to cancer. The polyp-cancer sequence is now well recognized. An accumulation of mutations in proto-oncogenes and tumor suppressor genes occurs, causing normal colonic epithelium to progress from dysplasia to adenoma and ultimately to carcinoma. Genes in whom mutations may occur and lead to the progression from polyp to cancer include adenomatous polyposis coli, Kirsten rat sarcoma virus, deleted in colon cancer, SMAD4, and p53. Other mutations involved in colorectal carcinogenesis include mutated in colon carcinoma, nm23-H1, CMYC gene, CSRC gene, and mismatch repair and microsatellite instability.

KEYWORDS

Adenoma-carcinoma sequence - polyp-cancer sequence - polyp growth - colorectal cancer - molecular genetics of colorectal cancer

REFERENCES

  • 1 Nivatvongs S. Benign neoplasms of the colon and rectum. In: Gordon PH, Nivatvongs, S, ed. Principles and Practice of Surgery for the Colon, Rectum, and Anus, 2nd ed St. Louis, MO: Quality Medical Publishing 1999: 541-573
    Google Scholar
  • 2 Goodman A A. Polypoid diseases. In: Corman ML, ed. Colon and Rectal Surgery, 4th ed Philadelphia: Lippincott-Raven 1998: 566-624
    Google Scholar
  • 3 Visvanathan R, Thambidorai C R, Myint H. Do dysplastic and adenomatous changes in large bowel hamartomas predispose to malignancy?.  <~>A report of two cases. Ann Acad Med Singapore . 1992;  21 830-832
    PubMedGoogle Scholar
  • 4 Muto T, Bussey H JR, Morson B C. The evolution of cancer of the colon and rectum.  Cancer . 1975;  36 2251-2270
    CrossrefPubMedGoogle Scholar
  • 5 Howe J R, Guillem J G. The genetics of colorectal cancer.  Surg Clin North Am . 1997;  77 175-195
    CrossrefPubMedGoogle Scholar
  • 6 Jass J R, Iino H, Ruszkiewicz A. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum.  Gut . 2000;  47 43-49
    CrossrefPubMedGoogle Scholar
  • 7 Rashid A, Houlihan P S, Booker S. Phenotypic and molecular characteristics of hyperplastic polyposis.  Gastroenterology . 2000;  119 323-332
    CrossrefPubMedGoogle Scholar
  • 8 Jass J R. Nature and clinical significance of colorectal hyperplastic polyp.  Semin Colon Rectal Surg . 1991;  2 246-252
    PubMedGoogle Scholar
  • 9 Jass J R. Hyperplastic polyps of the colorectum-innocent or guilty?.  Dis Colon Rectum . 2001;  44 163-166
    PubMedGoogle Scholar
  • 10 Haot J, Jouret A. Colonic dysplasia in polyps and flat lesions.  Acta Endoscop . 2000;  30 145-152
    PubMedGoogle Scholar
  • 11 Jass J R. Colorectal adenoma progression and genetic change: is there a link?.  Ann Med . 1995;  27 301-306
    PubMedGoogle Scholar
  • 12 Church J M, Williams B RG, Casey G. Molecular Genetics and Colorectal Neoplasia: A Primer for the Clinician.  New York: Igaku-Shoin; 1996
    Google Scholar
  • 13 Bjerknes M, Cheng H, Hay K, Gallinger S. APC mutation and the crypt cycle in murine and human intestine.  Am J Pathol . 1997;  159 833-839
    PubMedGoogle Scholar
  • 14 Navaratnam R M, Chowaniec J, Winslet M C. The molecular biology of colorectal cancer development and the associated genetic events.  Ann R Coll Surg Engl . 1999;  81 312-319
    PubMedGoogle Scholar
  • 15 Boland C R. The biology of colorectal cancer.  Cancer . 1993;  71 4180-4186
    PubMedGoogle Scholar
  • 16 Naveau S, Chaput J C, Bedossa P. Cirrhosis as an independent risk factor for colon adenomas.  Gut . 1992;  33 535-540
    PubMedGoogle Scholar
  • 17 Kikendall J W, Bowen P E, Burgess M B. Cigarettes and alcohol as independent risk factors for colonic adenomas.  Gastroenterology . 1989;  97 660-664
    PubMedGoogle Scholar
  • 18 Janne P A, Mayer R J. Chemoprevention of colorectal cancer.  N Engl J Med . 2000;  342 1960-1968
    CrossrefPubMedGoogle Scholar
  • 19 Fearon E R, Vogelstein B. A genetic model for colorectal tumorigenesis.  Cell . 1990;  61 759-767
    CrossrefPubMedGoogle Scholar
  • 20 Grinnell R S, Lane N. Benign and malignant adenomatous polyps and papillary adenomas of the colon and rectum. An analysis of 1,856 tumors in 1,335 patients.  Int Abstr Surg . 1958;  106 519-538
    PubMedGoogle Scholar
  • 21 Dukes C. Simple tumours of the large intestine and their relation to cancer.  Br J Surg . 1926;  13 720-733
    PubMedGoogle Scholar
  • 22 Swinton N W, Warren S. Polyps of the colon and rectum and their relation to malignancy.  JAMA . 1939;  113 1927-1933
    PubMedGoogle Scholar
  • 23 Jackman R J, Mayo C W. The adenoma-carcinoma sequence in cancer of the colon.  Surg Gynecol Obstet . 1951;  93 327-330
    PubMedGoogle Scholar
  • 24 O'Brien M J, Winawer S J, Zauber A G. The national polyp study-patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas.  Gastroenterology . 1990;  98 371-379
    PubMedGoogle Scholar
  • 25 Morson B C. Evolution of cancer of the colon and rectum.  Cancer . 1974;  34 845-849
    PubMedGoogle Scholar
  • 26 Fearnhead N S, Britton M P, Bodmer W F. The ABC of APC.  Hum Mol Genet . 2001;  10 721-733
    CrossrefPubMedGoogle Scholar
  • 27 Powell S M, Zilz N, Beazer-Barclay Y. APC mutations occur early during colorectal tumorigenesis.  Nature . 1992;  359 235-237
    CrossrefPubMedGoogle Scholar
  • 28 Prescott S M, White R L. Self-promotion?.  <~>Intimate connections between APC and prostaglandin H synthase-2. Cell . 1996;  87 783-786
    PubMedGoogle Scholar
  • 29 Cytogenetics. In: Gelehrter TD, Collins FS, eds. Principles of Medical Genetics Baltimore, MD: Williams & Wilkins 1990: 159-191
  • 30 Shibata D, Reale M A, Lavin P. The DCC protein and prognosis in colorectal cancer.  N Engl J Med . 1996;  335 1727-1732
    CrossrefPubMedGoogle Scholar
  • 31 Baker S J, Presisinger A C, Jessup J M. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.  Cancer Res . 1990;  50 7717-7722
    PubMedGoogle Scholar
  • 32 Shiota G, Ishida M, Noguchi N. Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.  Dig Dis Sci . 2000;  45 122-128
    CrossrefPubMedGoogle Scholar
  • 33 Watanabe T, Wu T T, Catalano P J, Ueki T. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.  N Engl J Med . 2001;  344 1196-1206
    CrossrefPubMedGoogle Scholar
  • 34 Molecular biology of colorectal cancer. Curr Probl Cancer . 1997;  21 235-299
    PubMed
  • 35 Cunningham J M, Boardman L A, Burgart L J, Thibodeau S N. Molecular abnormalities in colorectal cancer: microsatellite instability pathway.  Semin Colon Rectal Surg . 1998;  9 38-48
    PubMedGoogle Scholar
  • 36 Peddanna N, Mendis R, Holt S, Verma R S. Genetics of colorectal cancer (review).  Int J Oncol . 1996;  9 327-335
    PubMedGoogle Scholar